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Infertility is one of the predominant problems affecting around 
15% of couples of reproductive ages worldwide with about 50% of 
causative factors from the male side (Irvine, 1998; Lotti and Maggi, 
2018). In accordance with the World Health Organization (WHO) 
guidelines, the standard evaluation of fertility includes routine 
semen parameters such as ejaculate volume, pH, sperm count, 
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Our study objective was to assess the effect of various sperm DNA fragmentation 
levels on clinical intracytoplasmic sperm injection outcome. This retrospective study 
included 392 patients who underwent ICSI and performed sperm DNA fragmenta-
tion testing before the procedure. Based on sperm DNA fragmentation cut- off val-
ues, the patients were differentiated into 3 groups as <20%, 20%– 30% and >30%. 
According to the female status, patients were differentiated into favourable group 
(n = 259) with female age <35	years	and	anti-	Mullerian	hormone	level	≥7.1	pmol/L;	
and unfavourable group (n =	133)	with	female	age	≥35	years	and	anti-	Mullerian	hor-
mone	level	≤7.1	pmol/L.	The	patient's	medical	records	were	reviewed,	and	patient's	
demographic, laboratory data including semen analysis, sperm DNA fragmentation 
determined by means of sperm chromatin dispersion, hormonal profile and data re-
garding intracytoplasmic sperm injection cycle were collected. This cohort reported 
that the clinical reproductive outcomes of intracytoplasmic sperm injection showed 
no statistical significance with increase sperm DNA fragmentation levels. In sperm 
DNA fragmentation above 30%, favourable females had significantly higher clinical 
pregnancy rate and live birth rate than unfavourable females, while fertilisation rate 
and miscarriage rate showed no significance between the subgroups. High sperm 
DNA fragmentation is linked to poor semen parameters.
K E Y W O R D S
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total and progressive motility, vitality and morphology (World 
Health Organization, 2010). Yet, these parameters do not always 
predict male fertility, as infertile men might have normal semen 
parameters in up to 15% of cases (World Health Organization, 
2010).
Alternatively, sperm DNA fragmentation (SDF) testing pro-
vides a different parameter for the analysis of the male factors 
affecting fertility. In the recent years, SDF has been identified as 
a predictor of fertility with good reliability because sperm DNA 
integrity can impact fertilisation, embryogenesis, implantation 
and pregnancy outcomes (Majzoub, Agarwal, Cho et al., 2017; 
Majzoub, Agarwal, & Esteves, 2017). SDF may include breakage of 
single- strand DNA (ssDNA) or double- strand DNA (dsDNA), base 
deletion or modification, and inter- or intra- cross linkage (Sergerie 
et al., 2005). SDF occurs during late spermatogenesis due to de-
fects in the repair system of DNA (Bui et al., 2018) which can be 
caused by different pathological mechanisms including apoptosis, 
elevated oxidative stress due to an increase in reactive oxygen 
species (ROS), and dysregulation of the chromatin protamine and 
histone components. These changes may occur as a result of var-
ious factors like drug use, tobacco smoking, environmental pol-
lution, high testicular temperature, and advanced age (Sergerie 
et al., 2005). Furthermore, the impact of DNA damage on fertility 
outcome is not only believed to be influenced by sperm chromatin 
integrity, but also by the oocyte repair capacity. Oocytes play an 
important	role	in	repairing	SDF,	depending	on	the	oocyte's	cyto-
plasmic and genomic quality (Fernández- Díez et al., 2016, García- 
Rodríguez et al., 2018, Setti et al., 2021). The exact mechanism by 
which the oocyte can repair the SDF remains unknown although 
human oocytes occupy DNA repair genes and can be linked to ma-
ternal mRNA repair (Osman et al., 2015).
Various tests for SDF have been identified with Sperm Chromatin 
Structure Assay (SCSA), Sperm Chromatin Dispersion (SCD), Terminal 
deoxynucleotidyl transferase dUTP nick- end labelling (TUNEL) and 
Single Cell Gel Electrophoresis (COMET) being most commonly 
applied (Majzoub, Agarwal, Cho et al., 2017; Majzoub, Agarwal, & 
Esteves, 2017).
Recent efforts have identified implications of SDF on fertility 
and hence clinical guidelines were published highlighting the impor-
tance of SDF testing in couples with unexplained/idiopathic infer-
tility, recurrent natural pregnancy loss, clinical varicocele, lifestyle 
exposures, recurrent intrauterine insemination (IUI) and in vitro 
fertilisation (IVF) failure and recurrent miscarriages following ICSI 
(Agarwal et al., 2019). There is a contradiction in literature with re-
spect to the effect of SDF on fertilisation and pregnancy rates with 
ICSI. Evidence extracted from three meta- analyses has indicated 
that higher SDF is not associated with a negative impact on ICSI out-
comes (Zini, 2011; Li et al., 2006; Zhao et al., 2014). On the contrary, 
another meta- analysis by Simon et al. including 24 ICSI studies re-
vealed that SDF can have a significant impact on the pregnancy rate 
with an OR of 1.31 (95% CI 1.08– 1.59, p = .006) (Simon et al., 2017).
To bridge the above- mentioned gap regarding the role of SDF 
on ICSI, our aim in the current study was to investigate the effect of 
different levels of SDF on ICSI in our centre with regard to fertilisa-
tion, clinical pregnancy, live birth and abortion.
2  | METHODOLOGY
This is a retrospective cohort study which was carried out in the as-
sisted conception unit at Hamad Medical Corporation, Doha, Qatar. 
The study duration was over a 5- year period from 1 August 2014 to 
1 August 2019. Ethical Approval from the Institutional Review Board 
was obtained (IRB MRC- 01- 19- 349) for the protocols and proce-
dures of this study.
The charts of 1922 patients who underwent ICSI were screened 
for inclusion in the study. Inclusion criteria were patients that under-
went ICSI using ejaculated spermatozoa and had a recorded sperm 
DNA fragmentation (SDF) test done within a week before ICSI. 
While couples with (a) severe male factor (severe oligozoospermia, 
azoospermia), (b) male genetic abnormalities, (c) female factor infer-
tility (tubal factor, uterine abnormality, PCO), (d) history of mumps 
orchitis, (e) history of receiving chemotherapy or radiotherapy, and 
(f) history of testicular tumour were excluded.
The electronic medical records of male patients and their female 
partners were reviewed by two investigators for extraction of data 
including	 patients'	 age,	 related	 past	 medical	 history,	 any	 surgical	
procedure of relevance to fertility, consanguinity or history of in-
fertility in the family. Clinical examination data involving general and 
local genital examination as well as laboratory data including semen 
analysis, SDF and hormonal profile (FSH, LH, Testosterone, PRL and 
E2) were extracted. Data retrieved for the female partners included 
basal FSH, anti- Mullerian hormone (AMH) and oestradiol. All infor-
mation regarding the ICSI cycle was extracted from the medical re-
cords of the spouse including the protocol for ovarian stimulation 
and different ICSI outcomes.
2.1 | Procedures
2.1.1 | Semen	analysis
Following 3– 5 days of sexual abstinence, patients were asked to 
produce semen samples by masturbation. After liquefaction, semen 
analysis was carried out according to World Health Organization, 
2010 standard protocol (WHO 5th edition guidelines).
2.1.2 | Sperm	DNA	fragmentation	test
The Halosperm G2 test kit (Halotech, Madrid, Spain) was used to 
determine SDF. This test can be performed upon fresh and frozen 
semen samples. The SCD process is an indirect method of observing 
sperm DNA damage. During the test, controlled acid denaturation of 
the DNA and removal of nuclear proteins of the semen sample takes 
place. As a result, a large halo can be seen in sperm with intact DNA 
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by using fluorescence microscope, while spermatozoon with dis-
persed chromatin materials or fragmented DNA will not produce a 
halo.	SDF	cut-	off	value	was	taken	as	≥30%	to	differentiate	between	
infertile and fertile men using a standard protocol (Fernández et al., 
2005).
2.1.3 | Reproductive	hormones
Hormonal assays were done using the immunoassay chemilumi-
nescence method, Architect i1000SR® (Abbott systems). The rel-
evant blood samples were drawn in the early morning between 7 
and 9 a.m. The testing included follicle- stimulating hormone (FSH) 
(range = 1– 19 IU/L), luteinising hormone (LH) (range = 1– 9 IU/L), 
prolactin (range = 73– 407 mIU/L), total testosterone (range = 10.4– 
35 nmol/L) and oestradiol (range = 73– 275 pmol/L).
2.1.4 | Study	protocol	for	ICSI
Patients performed an ICSI trial using ejaculated spermatozoa. 
Ovarian stimulation in a controlled manner was started using re-
combinant FSH after desensitisation of pituitary with the dose 
guided by patient age, previous ovarian stimulation, oestradiol 
level and follicles scanned on ovarian transvaginal ultrasound 
scans (Yim et al., 2001). Continued monitored stimulation was 
done until at least two follicles matured and reached a mean di-
ameter of 18 mm. Ovulation induction was then performed using 
10,000 IU subcutaneous of hCG 36 hr before oocyte retrieval. 
Oocytes were aspirated guided by transvaginal ultrasound. 
Following ICSI, fertilised oocyte culturing was done, and the em-
bryo quality was evaluated using the Veeck score. Embryo trans-
fer was carried out on day 2 or 3 and patients were then daily 
given vaginal progesterone (Crinone 8%) for luteal phase support. 
(Veeck, 1988).
2.2 | Statistical analyses
The Shapiro- Wilk test for normality was performed to identify the 
distribution of the study variables. Frequencies were used to report 
categorical data, while median [95% CI] were used to present contin-
uous	values.	Spearman's	correlations	were	performed	to	assess	the	
relationship between various study variables. The chi- square test 
was used to compare ICSI outcomes in various SDF levels. Kruskal- 
Wallis test was used to compare continuous variables between the 
three	SDF	levels.	The	Jonckheere-	Terpstra	test	was	used	to	test	for	
an ordered difference in medians of the three SDF levels stating 
the direction of this order (trend). A p- value below .05 was consid-
ered statistically significant. All statistical analyses of collected data 
were performed using MedCalc® Statistical Software version 19.8 
(MedCalc Software Ltd).
3  | RESULTS
The records of 1,922 patients who underwent ICSI from 2014 to 
2019 were screened in our study. A total of 392 patients had SDF 
data within 7 days before the ICSI procedure were included after 
applying the inclusion and exclusion criteria. There were 63.5% 
of the patients complaining of primary infertility (n = 249) and 
36.5% of secondary infertility (n = 143). The mean male age was 
37.32 ± 6.7 years while the mean female age was 33.8 ± 6.1 years.
Table 1 shows the clinical characteristics of the whole study 
population (n = 392) including semen parameters, hormonal anal-
ysis,	and	testicular	size.	As	for	the	whole	patients'	samples,	clinical	
pregnancy occurred in 44.1% (173/392) of the cases, live birth rate 
was 34.4% (121/352), and 9% (12/134) of patients had miscarriage.
Table 2 shows correlations between SDF and different clinical pa-
rameters. There was a highly significant negative correlation between 
SDF and sperm count and motility, while there was a highly significant 
positive correlation between SDF and abnormal morphology. No correla-
tion could be found between SDF and male age and progressive motility.
The patients were grouped according to SDF value into three 
groups, SDF <20% (n = 156), SDF 20%– 30% (n = 149), and SDF 
>30% (n = 87). Table 3 shows the comparison between the three 
SDF groups with regard to semen and hormone parameters. Semen 
volume, sperm total motility and normal morphology were signifi-
cantly different between the 3 groups with higher values found in 
lower SDF groups. No statistical significance was observed for age, 
testis site, sperm concentration, sperm progressive motility and hor-
mones between SDF groups. However, there was a trend of better 
sperm concentration and lower FSH levels in patients with low SDF.
Fertilisation (p = .441), clinical pregnancy (p = .265) and live birth 
rates (p = .861) were greater in patients with lower SDF than in those 
with higher SDF. However, the difference was insignificant. Similarly, 
TA B L E  1   Characteristics of study population
Clinical parameter
Value (n = 392) 
(median; mean ± SD)
Semen analysis data
Volume (ml) 2.1; 2.2 ± 1.8
Concentration (106/ml) 32.0; 42.9 ± 36.8
Total motility (%) 42.0; 41.1 ± 18.4
Prog. motility (%) 14.5; 18.8 ± 18.7
Normal morphology (%) 6.0; 12.1 ± 12.6
DNA fragmentation (%) 20.5; 25.0 ± 14.6
Hormone data
Oestradiol (pmol/L) 92.0; 104.3 ± 55.7
FSH (mIU/ml) 2.9; 3.6 ± 2.9
LH (mIU/ml) 3.3; 4.1 ± 2.9
Testosterone (nmol/L) 16.0; 17.8 ± 9.5
Abbreviations: FSH, follicle- stimulating hormone; LH, luteinising 
hormone; ORP, oxidation reduction potential; Prog. Motility, 
progressive motility.
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miscarriage (p = .121) was higher with high SDF but again the differ-
ence was insignificant (Table 4).
Patients were then subgrouped according to the female sta-
tus into favourable group (female age <35 years and AMH value 
>/ = 7.1 pmol/L) which included 259 patients and unfavourable 
group (female age >/ = 35 years and AMH value <7.1 pmol/L) 
which included 133 patients. Table 5 shows the difference in the 
ICSI outcome within the 3 SDF groups with regard to favourabil-
ity subgrouping. In groups with SDF <20% and 20— 30%, fertili-
sation, clinical pregnancy and live birth rates were greater in the 
favourable subgroup compared to unfavourable subgroup; how-
ever, the difference was insignificant. In the SDF >30% group, 
clinical pregnancy and live birth rate were significantly higher 
in the favourable subgroup compared to unfavourable subgroup 
(p = .005 and p = .024 respectively) but fertilisation was insig-
nificant. We compared ICSI outcome (fertilisation rate, clinical 
pregnancy, live birth rate and miscarriage) between different fe-
male status within each SDF group (young age/high AMH, young 
age/low AMH, old age/low AMH, old age/high AMH). We could 
confirm that favourable females (young age and high AMH) had 
significantly higher pregnancy rate and live birth rate than unfa-
vourable females (Tables S1– S4).
4  | DISCUSSION
The current study examined the impact of SDF, measured with the 
SCD test, on the reproductive outcomes with ICSI; namely, clinical 
pregnancy, live birth, fertilisation, and miscarriage rates. The results 
showed	that	different	SDF	levels	didn't	affect	the	clinical	outcome	
of ICSI with regard to fertilisation rate, clinical pregnancy, live birth 
rate and miscarriage rate in the whole sample. Patients with low SDF 
showed better outcome than higher SDF; however, the difference 
was insignificant.
High SDF has been linked with worse conventional semen param-
eters in a number of studies. Tie- Cheng et al. in 2018 used the SCD 
test in a cohort of 152 ICSI patients, that were subgrouped into <30% 
SDF and >30% SDF. They reported significantly lower total (p = .001) 
and progressive motility (p < .001) in the >30% SDF group in com-
parison to the <30% SDF group. Additionally, the authors showed a 
significant negative correlation between SDF and normal morphology. 
Similarly, Antonouli et al. revealed a significant negative correlation 
between total and progressive motility and SDF (r =	−.29	total	motility,	
p = .012: r =	−.27	PM,	p = .019) (Antonouli, 2019). Our present study 
showed significantly higher total motility and normal morphology in 
low SDF patients, but progressive motility was insignificant.












.121* −.132* −.294** −.055 −.183** .012
p value .016 .009 .000 .278 .000 .819
Note: Spearman test (r2). *Significant (p < .05), **Highly significant (p < .001)
TA B L E  3   Comparison between three groups of SDF: semen and hormone parameters
SDF <20 (n = 156)
(mean ± SD)
SDF 20– 30 (149)
(mean ± SD)
SDF>30 (n = 87)
(mean ± SD)
p value
Kruskal- Wallis (Jonckheere- Terpstra)
Age 35.4 ± 6.7 37.3 ± 7.2 38.0 ± 9.1 .132 (0.016)
Semen
Volume (ml) 2.3 ± 1.8 2.1 ± 1.8 2.2 ± 2.0 .049 (0.828)
Concentration (million/ml) 47.0 ± 42.2 44.2 ± 32.5 33.5 ± 31.5 .062 (0.008)*
Total motility (%) 46.2 ± 17.7 42.4 ± 16.9 30.0 ± 17.4 .002* (0.000)**
Prog. motility (%) 20.0 ± 20.1 20.1 ± 18.7 14.3 ± 15.6 .691 (0.254)
Normal morph. (%) 12.4 ± 11.6 13.5 ± 14.1 8.9 ± 11.1 .018* (0.000)**
Hormones
Oestradiol (pmol/L) 97.0 ± 52.6 111.3 ± 59.3 105.5 ± 54.2 .371 (0.527)
FSH (IU/L) 3.2 ± 2.5 3.9 ± 3.3 3.9 ± 2.7 .269 (0.041)*
LH (IU/L) 3.8 ± 2.3 4.1 ± 2.8 4.5 ± 3.7 .179 (0.188)
Testosterone (mmol/L) 17.3 ± 9.6 18.6 ± 10.1 17.1 ± 7.9 .984 (0.931)
Abbreviations: FSH, follicle- stimulating hormone; LH, luteinising hormone; Normal morph., normal morphology; Prog. motility, progressive motility; 
SDF, sperm DNA fragmentation. *Significant (p < .05), **Highly significant (p < .001)
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In the present study, we could not find a statistically significant 
correlation between male age and SDF. While male age is believed 
to be a risk factor for elevated SDF due to the existence of elevated 
levels of oxidative stress, defective sperm chromatin packaging, 
and disordered apoptosis that occur with ageing (Agarwal and Said, 
2003), the reported evidence remains to be contradictory. Petersen 
et al. (2018) evaluated SDF across different male age subgroups, 
≤35	years,	36–	44	years,	and	≥45	years	in	a	cohort	of	2,176	semen	
samples of infertile men, these authors reported lower levels of SDF 
(percentage of SDF; 15.9 ± 8.7, TUNEL) in the 35– 44- year age group 
compared	to	≥45	years	age	group	(percentage	of	SDF;	16.2	± 8.4; 
TUNEL).	Moreover,	 the	youngest	age	group,	males	≤35	years,	had	
the lowest level of SDF. Similarly, Antonouli et al. (2019) found a 
significant positive correlation between the SDF level and male age 
(r = 0.23, p = .046). On the other hand several other studies, echoing 
our results, failed to report any significant correlation between male 
age and SDF (Sun et al., 1997; Winkle et al., 2009; Colin et al., 2010; 
Brahem et al., 2011; Nijs et al., 2011).
Our data show that there is no significance between SDF groups 
as regards clinical pregnancy, fertilisation rate, miscarriage rate 
and live birth rate. This result is in agreement with other studies. 
Antonouli et al. used the SCD test to measure SDF within 150 pa-
tients and found no significant correlation between SDF and fertil-
isation rate in ICSI patients (Antonouli, 2019). Sun et al. also used 
SCD in ICSI patients and found no significant difference between 
<30%	SDF	and	≥30%	groups	as	regards	ICSI	outcome	(p = .458) (Sun 
et al., 2018). The impact of SDF on ICSI outcome is believed to be un-
dermined by the sperm selection processes that usually choose the 
best quality sperm, i.e. with lower SDF, for the procedure. Indeed, 
Liffner et al. measured SDF levels in selected sperm using a colloid 
discontinuous gradient for patients with high SDF and reported lev-
els that were even lower than those of normozoospermic donors 
(Liffner et al., 2019).
In the current study, SDF was found to have no significant effect 
on clinical pregnancy. This finding was in agreement with a study 
by Simon and coworkers who found that there was no significant 
correlation between SDF and clinical pregnancy following ICSI 
(Simon, 2013). Similarly, another systematic review by Agarwal and 
coworkers found that there was no correlation between SDF and 
clinical pregnancy rate (OR 0.94, 95% CI) (Cho and Agarwal, 2018). 
Moreover, in a study by Antonouli et al. (2019) in a cohort of 150 
couples with donated oocytes, SCD was utilised at a cut- off value 
of 25% to test its correlation with ICSI outcome. The study found 
that there was no statistically significant difference in pregnancy 
outcome between low SDF (< 25%) and high SDF (> 25%) groups 
(pregnancies 68.2% and 65.1% respectively). Additionally, Sun and 
coworkers concluded that using a 30% cut- off value, that there was 
no significant effect of SDF on IVF and ICSI outcomes using SCD 
(Tie- Cheng, 2018). On the contrary, in a recent meta- analysis on 24 
ICSI studies, the authors concluded that there was a negative sig-
nificant correlation between SDF and clinical pregnancy rate (OR 
1.31, 95% CI, p < .007) (Simon, 2013). The discrepancy whether SDF 
correlates to clinical pregnancy can be caused by the use of differ-
ent SDF tests. Concerning SCD, used in both the present study and 
Tie- Cheng et al study, no significant correlation between SDF and 
ICSI clinical pregnancy rate. Regarding SCSA studies, a meta- analysis 
demonstrated a highly significant correlation between clinical preg-
nancy and SDF, where groups with SDF <27% are more likely to have 
a positive ART outcome than SDF >27% groups (OR = 1.437, 95% CI, 
p = .000) (Zhang et al., 2015). Besides, a meta- analysis and system-
atic review, pooled 8,068 treatment cycles of which there 2,359 SCD 
cycles (29.2%), and their random effects model combined 24 ICSI OR 
estimates (OR = 1.49; 95% CI: 1.11– 2.01; p = .0075) showed a highly 
significant correlation between high SDF and low clinical pregnancy 
rate (Simon et al., 2017). However, since they used a variety of SDF 
tests, it was unclear if there was a specific correlation between SDF 
measured by SCD and clinical pregnancy following ICSI.
With regard to live birth rate (LBR), we could not find a sig-
nificant effect of SDF in our results. A study conducted by Simon 
et al. (2013) involving 136 couples undergoing ICSI showed no re-
lationship between sperm DNA damage and live birth rates. On the 
contrary, in 2015, Osman et al found a detrimental effect of high 
DNA fragmentation on LBR, in IVF and ICSI patients.
We subclassified the groups according to female factors (ad-
vanced age and AMH value) into favourable group (female age 
<35 years and AMH value >/ = 7.1 pmol/L) and unfavourable group 
(female age >/ = 35 years and AMH value <7.1 pmol/L, n = 140). We 
found no statistical difference in the fertilisation rate, clinical preg-
nancy rate, live birth rate and miscarriage rate between favourable 
and unfavourable subgroups in patients with SDF <20% and 20%– 
30%. However, in the high SDF group (>30%) clinical pregnancy 
rate and live birth rate were significantly higher in the favourable 
subgroup while fertilisation rate and miscarriage were insignificant. 
This could be explained by the fact that oocytes retrieved from 
TA B L E  4   Comparison between three groups of SDF: ICSI outcome
SDF<20 (n = 156) SDF 20– 30 (n = 149) SDF>30 (n = 87)
p value Kruskal- Wallis 
(Jonckheere- Terpstra)
Fertilisation (mean ± SD) 70.9 ± 23.1 74.3 ± 21.9 70.8 ± 20.7 .441 (0.814)
Clinical Pregnancy (% [n/total]) 33.3% (52/156) 41.6% (62/149) 34.5% (30/87) .265 (0.484)
Miscarriage (% [n/total]) 6% (3/50) 8.6% (5/58) 15.4% (4/26) .121 (0.550)
Live birth (% [n/total]) 34.1% (47/138) 38.4% (53/138) 27.6% (21/76) .380 (0.861)
Abbreviation: SDF, Sperm DNA Fragmentation
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younger more favourable females had more capacity to repair SDF 
in the sperm during embryogenesis (Fernández- Díez et al., 2016, 
García- Rodríguez et al., 2018, Setti et al., 2021). This is contra-
dictory to the results of the meta- analysis by Osman et al female 
subgroup analysis where she subclassified her patients accounting 
for female factors such as advanced age and ovarian reserve. They 
reported that SDF did not have an effect on LBR in ICSI patients 
(Osman et al., 2015).
The main limitation of our study was the retrospective nature of 
the study with the possibility of incomplete data. However, we ex-
tensively searched in all medical records of both spouses in addition 
to assisted conception unit records to overcome this limitation. The 
data were also retrieved from one ART centre in Qatar; therefore, 
our data lacked diversity within methodologies for IVF and SDF test-
ing, as well as lacked geographical distribution. However, the geo-
graphical	distribution	should	not	be	a	problem	in	our	patients'	cohort	
because we are serving patients from more than 117 countries from 
different geographical and ethnic backgrounds. A prospective, mul-
ticentre study on the effect of SDF on ICSI outcome is highly recom-
mended to consolidate the data on this issue.
5  | CONCLUSION
Sperm DNA fragmentation was found to be significantly corre-
lated with conventional semen parameters highlighting its signifi-
cance as a robust diagnostic test during male fertility evaluation. 
In this study, while patients with higher SDF values had worse re-
productive outcomes with ICSI, the results did not reach statistical 
significance. In case of older female age with lower ovarian re-
serve, if the husband has high sperm DNA fragmentation this will 
significantly affect ICSI outcome with regard to clinical pregnancy 
and live birth rate. Therefore, in these cases, more intervention is 
needed through sperm selection methods either intracytoplasmic 
morphologically selected sperm injection (IMSI), physiological in-
tracytoplasmic sperm injection (PICSI) or using testicular sperm 
for ICSI.
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